HIV Vaccine created in Canada

                                                                 Dr. Chil-Yong Kang

It would appear that a major breakthrough has been made in the area of HIV vaccination as according to a news report, a Canadian-developed vaccine to prevent HIV has been given the go-ahead for testing in human clinical trials.
In an announcement made in London, researchers at the University of Western Ontario developed the vaccine, which has been approved by the U.S. Food and Drug Administration to start being tested on humans in January.
The Canadian News reported the story as follows:

It is the first preventive HIV vaccine approved for clinical trials to use a whole HIV-1 virus, which has been both killed and genetically engineered, to activate immunity. In this way, the new vaccine is much like the killed whole virus vaccines that are successful against polio, rabies and influenza.
Other HIV vaccines currently in clinical human trials have largely focused on one specific component of HIV to trigger an immune response. Right now, there is no effective HIV vaccine.
“FDA approval for human clinical trials is an extremely significant milestone for our vaccine, which has the potential to save the lives of millions of people around the world by preventing HIV infection,” said Dr. Chil-Yong Kang, professor of virology at the Schulich School of Medicine and Dentistry at the University of Western Ontario, in a release.(1976ad)